The Impact of Radiotherapy on Oligometastatic Cancer
Status: RECRUITING
Study type: OBSERVATIONAL
Conditions: Metastasis|Metastatic Breast Cancer|Metastatic Prostate Cancer|Metastatic Colorectal Cancer|Metastatic Lung Cancer
Interventions: DIAGNOSTIC_TEST: To propose a diagnostic test to determine the viability of Stereotactic ABlative Radiotherapy (SABR).|DIAGNOSTIC_TEST: To propose a diagnostic test to determine the effectiveness of SABR.|DIAGNOSTIC_TEST: To propose a diagnostic test for Oligometastatic Cancer (OC).
Sponsor: Institut Investigacio Sanitaria Pere Virgili
Collaborators: HM Sanchinarro University Hospital|Hospital Ruber Internacional|Hospital Universitario Rey Juan Carlos|Quirón Madrid University Hospital|Hospital de La Luz|Institut Català d'Oncologia|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|Hospital Vall d'Hebron|Hospital Arnau de Vilanova|Hospital Universitari Sant Joan de Reus|Hospital Miguel Servet|Hospital Universitario Virgen Macarena|Hospital Universitario Reina Sofia de Cordoba|University Hospital Virgen de las Nieves|Hospital General Universitario de Valencia|Hospital Clínico Universitario de Valencia|Complejo Hospitalario Universitario de Albacete|Hospital de Terrassa|Hospital Universitario Ramon y Cajal|Hospital del Mar|Hospital Provincial de Castellon